ACAD
ACADIA PHARMACEUTICALS INC
Pharmaceutical Preparations- 売上
- $1.1bn
- 時価総額
- $4.4bn
株価 $26.01 · 100株 2,601円
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $726m | $958m | $1.1bn |
| 成長率 | — | 31.8% | 11.9% |
| 総利益 | $685m | $685m | $685m |
| 総利益率 | 94.3% | 71.5% | 63.9% |
| 販管費 | $407m | $488m | $549m |
| 販管費率 | 56.0% | 51.0% | 51.2% |
| 営利 | ▲$73m | $231m | $105m |
| 営利率 | ▲10.1% | 24.1% | 9.8% |
| 純利益 | ▲$61m | $226m | $391m |
| PBR | 10.3 | 6.0 | 3.6 |
| PSR | 6.1 | 4.6 | 4.1 |
| PGPR | 6.5 | 6.5 | 6.5 |
| PER | — | 20 | 11 |
| ﾈｯﾄｷｬｯｼｭ | $189m | $320m | $178m |
| EV/EBITDA | — | 17.8 | 40.5 |
| Rule of 40 | — | 56% | 22% |
| セールス効率 | — | 0% | 0% |
※Rule of 40は売上成長率＋営業利益率、セールス効率は売上総利益増加÷販管費増加（販管費増のときのみ）